Market closedNon-fractional

Pacific Biosciences/PACB

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Pacific Biosciences

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Ticker

PACB

Sector

Healthcare

Trading on

NASDAQ

Industry

Life Sciences Tools and Services

Headquarters

Menlo Park, United States

Employees

796

PACB Metrics

BasicAdvanced
$354M
Market cap
-
P/E ratio
-$1.14
EPS
1.98
Beta
-
Dividend rate
$354M
1.98
9.281
8.118
143.504
143.504
-21.65%
-10.84%
-44.28%
1.69
0.55
-1.35
-1.359
49.54%
-18.18%
29.50%
50.01%

What the Analysts think about PACB

Analyst Ratings

Majority rating from 14 analysts.
Hold

PACB Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-201.28% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$39M
-33.45%
Net income
-$78M
-4.76%
Profit margin
-201.28%
43.11%

PACB Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 5.31%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.28
-$0.26
-$0.31
-$0.29
-
Expected
-$0.32
-$0.33
-$0.29
-$0.28
-$0.23
Surprise
-12.67%
-20.76%
8.70%
5.31%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Pacific Biosciences stock?

Pacific Biosciences (PACB) has a market cap of $354M as of July 06, 2024.

What is the P/E ratio for Pacific Biosciences stock?

The price to earnings (P/E) ratio for Pacific Biosciences (PACB) stock is 0 as of July 06, 2024.

Does Pacific Biosciences stock pay dividends?

No, Pacific Biosciences (PACB) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Pacific Biosciences dividend payment date?

Pacific Biosciences (PACB) stock does not pay dividends to its shareholders.

What is the beta indicator for Pacific Biosciences?

Pacific Biosciences (PACB) has a beta rating of 1.98. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Pacific Biosciences stock

Buy or sell Pacific Biosciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing